Risk Factors of Hyperammonemia in Patients with Epilepsy Under Valproic Acid Therapy
Medicine 93:e66, Tseng, Y.L.,et al, 2014
Chitosan May Decrease Serum Valproate and Increase Risk of Seizure Reappearance
BMJ 339:a2163, Striano,P.,et al, 2009
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
Effect of Food on the Serum Concentration Profile of Enteric-Coated Valproic Acid
Neurol 38:1319-1322, Fischer,J.H.,et al, 1988
Plasma Concentrations of Sodium Valproate:Their Clinical Value
Ann Neurol 14:38-42, Turnbull,D.M.,et al, 1983
Phenytoin-valproate Interaction:Importance of Saliva Monitoring in Epilepsy
BMJ 284:13-16, Knott,C.,et al, 1982
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Protein Binding of Valproic Acid in Uremic Patient
Neurol 30:557-559, Bruni,J.,et al, 1980
Valproic Acid & Ethosuximide Interaction
Ann Neurol 7:583-584, Mattson,R.H.,et al, 1980
Valproic Acid, Review of a New Antiepileptic Drug
Arch Neurol 36:393-398, Bruni,J.,et al, 1979
Acute Intoxication with Sodium Valproate
Ann Neurol 6:552-553, Chadwick,D.W.,et al, 1979
Valproic Acid in Epilepsy:Clinical & Pharmacological Effects
Ann Neurol 3:20, Mattson,R.H.,et al, 1978
Sodium Valproate in the Treatment of Intractable Seizure Disorders:A Clinical & Electroencephalographic Study
Neurol 28:152, Adams,D.,et al, 1978
Valproic Acid:Interaction with Other Anticonvulsant Drugs
Neurol 28:892-896, Wilder,B.J.,et al, 1978
Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003
Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Valproic Acid-Induced Hyperammonemic Encephalopathy:MR Appearance
AJNR 15:1779-1781, Baganz,M.D.&Dross,P.E., 1994
Comparison of Sprinkle Versus Syrup Formulations of Valproate for Bioavailability, Tolerance, and Preference
J Pediatr 120:634-638, Cloyd,J.C.,et al, 1992
Breakthrough Seizure Following Substitution of Depakene Capsules with a Generic Product
Neurol 37:1885, MacDonald,J.T., 1987
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Risk of 23 Specific Malformations Associated with Prenatal Exposure to 10 Antiepileptic Drugs
Neurol 93:e167-e180, Blotiere, P.O.,et al, 2019
Declining Malformation Rates with Changed Antiepileptic Drug Prescribing, An Observational Study
Neurol 93:e831-e840, Tomson,T.,et al, 2019
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
Maternal Use of antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children
JAMA 318:1700-1701, Bromley, R.L.,et al, 2017
Fetal Effects of Anticonvulsant Polytherapies
Arch Neurol 68:1273-1279, Holmes, L.et al, 2011
Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
NEJM 362:2185-2193, Jentink,J., et al, 2010
Bone Health in Young Women With Epilepsy After One Year of Antiepileptic Drug Monotherapy
Neurol 70:1586-1593, Pack,A.M.,et al, 2008
Intravenous Sodium Valproate Versus Diazepam Infusion for the Control of Refractory Status Epilepticus in Children: A Randomized Controlled Trial
J Child Neurol 22:1191-1197, Mehta,V.,et al, 2007
Malformation Risks of Antiepileptic Drugs in Pregnancy: A Prospective Study from the UK Epilepsy and Pregnancy Register
JNNP 77:193-198,145, Morrow,J.,et al, 2006
Prenatal Exposure to Antiepileptic Drugs
Lancet 367:1467-1469, Perucca,E. &Tomson,T., 2006
Sodium Valproate vs Phenytoin in Status Epilepticus: A Pilot Study
Neurol 67:340-342, Misra,U.K.,et al, 2006
In Utero Antiepileptic Drug Exposure: Fetal Death and Malformations
Neurol 67:407-412, Meador,K.J.,et al, 2006
Teratogenicity of Antiepileptic Drugs
BMJ 333:615-616, Breen,D.P. &Davenport,R.J., 2006
Increased Rate of Major Malformations in Offspring Exposed to Valproate Durng Pregnancy
Neurol 64:961-965, 938, Wyszynski,D.F., et al, 2005
Antiepileptic Drug Use of Women with Epilepsy and Congenital Malformations in Offspring
Neurol 64:1874-1878, Artama,M.,et al, 2005
Normal Intelligence in Children with Prenatal Exposure to Carbamazepine
Neurol 62:28-32,8, Gaily,E.,et al, 2004
Valproate Embryopathy in Three Sets of Siblings: Further Proof of Hereditary Susceptibility
Neurol 59:630-633, Malm,H.,et al, 2002
Valproate, Hyperandrogenism, and Polycystic Ovaries
Arch Neurol 57:1064-1068, Isojarvi,J.I.T. & Tapanainen,J.S., 2000
Antiepileptic Drug Regimens and Major Congenital Abnormalities in the Offspring
Ann Neurol 46:739-746, Samren,E.B.,et al, 1999
Status Epilepticus
NEJM 338:970-976, Lowenstein,D.H.&Alldredge,B.K., 1998
Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998
Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998
Risk of Serious Cutaneous Disorders after Initiation of Use of Phenytoin, Carbamazepine, or Sodium Valproate
Neurol 49:542-546, Tennis,P.&Stern,R.S., 1997
Random Comp Monother Trial of Phenobarb, Phenytoin, Carbamazepine, or Sod Valp for Newly Dx Child Epilep
Lancet 347:709-713, deSilva,M.,et al, 1996
Obesity and Endocrine Disorders in Women Taking Valproate for Epilepsy
Ann Neurol 39:579-584, 5591996., Isojarvi,J.I.T.,et al, 1996
Phenobarbitone, Phenytoin, Carbamazepine, or Sodium Valproate for Newly Diagnosed Adult Epilepsy:A Randomized Monotherapy Trial
JNNP 58:44-50, Heller,A.J.,et al, 1995
Rational Polypharmacy in the Treatment of Epilepsy
(Ed) , Neurol (suppl) 45:S1-S38., Wilder,B.J., 1995